- Home
- CMMB vs ECDA Comparison
CMMB vs ECDA Comparison
Compare CMMB & ECDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMMB
- ECDA
- Stock Information
- Founded
- CMMB 2004
- ECDA 2013
- Country
- CMMB Israel
- ECDA United States
- Employees
- CMMB N/A
- ECDA N/A
- Industry
- CMMB Biotechnology: Pharmaceutical Preparations
- ECDA Auto Manufacturing
- Sector
- CMMB Health Care
- ECDA Consumer Discretionary
- Exchange
- CMMB Nasdaq
- ECDA Nasdaq
- Market Cap
- CMMB 32.2M
- ECDA 34.8M
- IPO Year
- CMMB N/A
- ECDA N/A
- Fundamental
- Price
- CMMB $1.71
- ECDA $0.84
- Analyst Decision
- CMMB Strong Buy
- ECDA
- Analyst Count
- CMMB 2
- ECDA 0
- Target Price
- CMMB $9.00
- ECDA N/A
- AVG Volume (30 Days)
- CMMB 835.3K
- ECDA 33.9K
- Earning Date
- CMMB 03-06-2025
- ECDA 03-04-2025
- Dividend Yield
- CMMB N/A
- ECDA N/A
- EPS Growth
- CMMB N/A
- ECDA N/A
- EPS
- CMMB N/A
- ECDA N/A
- Revenue
- CMMB N/A
- ECDA $25,728,409.00
- Revenue This Year
- CMMB N/A
- ECDA $125.56
- Revenue Next Year
- CMMB N/A
- ECDA $36.05
- P/E Ratio
- CMMB N/A
- ECDA N/A
- Revenue Growth
- CMMB N/A
- ECDA 123.27
- 52 Week Low
- CMMB $0.58
- ECDA $0.75
- 52 Week High
- CMMB $2.55
- ECDA $1.55
- Technical
- Relative Strength Index (RSI)
- CMMB 32.89
- ECDA 45.31
- Support Level
- CMMB $1.66
- ECDA $0.82
- Resistance Level
- CMMB $2.06
- ECDA $0.95
- Average True Range (ATR)
- CMMB 0.16
- ECDA 0.08
- MACD
- CMMB -0.04
- ECDA 0.00
- Stochastic Oscillator
- CMMB 9.43
- ECDA 41.54
About CMMB Chemomab Therapeutics Ltd.
Chemomab Therapeutics Ltd is a clinical-stage biotech company, focusing on the discovery and development of therapeutics for fibrosis-related diseases with large unmet needs. The company's candidate, CM-101, is a monoclonal antibody that targets CCL24 and was shown to interfere with the underlying biology of liver, skin and lung fibrosis using a novel and differentiated mechanism of action. CM-101 has demonstrated the potential to treat multiple severe and life threatening fibrotic and inflammatory diseases. It is advancing three Phase 2 clinical trials in parallel for CM-101 treating rare fibrotic conditions.
About ECDA ECD Automotive Design Inc.
ECD Automotive Design Inc is a custom-car builder in the Restomod sector with a focus on British classic motor vehicles of various models of both two-door and four-door styles. The company has established a facility geared towards producing the most customized Land Rovers with the highest quality of parts and the highest quality labor force building each vehicle. ECD restores Land Rovers Defenders, Land Rover Series IIA, the Range Rover Classic and the Jaguar E-Type. It upgrade any engine, including Chevrolet V8's, Land Rover V8's, Cummins diesel engines and new electric drivetrains, performing all the necessary body work, drivetrain selection and installation, every stitch in the interior, paint work, up to placement of the last nut and bolt.